THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-07-01 pm EDT
548.27 USD   +0.92%
06/30Hywin Holdings, FactSet Launch Global Health Care Index
MT
06/14S&P Upgrades Thermo Fisher Scientific One Notch To 'A-' On Expected Leverage Below 3x and Strong Demand; Outlook Stable
MT
06/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific and LabShares Newton Partner to Support Emerging Boston Biotechs

05/19/2022 | 08:30am EDT

To support the Greater Boston biotech ecosystem, Thermo Fisher Scientific is joining forces with biotech incubator LabShares Newton to provide instruments, lab equipment and consumables to help early-stage life sciences companies accelerate their drug discovery efforts. LabShares provides fully furnished lab space, services and equipment to more than 25 biotech companies, alleviating logistics constraints to help them bring novel therapeutics to market. Thermo Fisher will outfit the shared lab space with equipment including ultra-low temperature freezers, cell culture incubators, microscopes and PCR instruments. While investment in the biotech industry continues to climb, the high cost of bringing drugs through research and development to the market is limiting many early-stage companies from flourishing. By offering alternative lab space and more tailored support and resources, LabShares and its partners are helping emerging biotech companies clear hurdles that previously hindered growth for smaller companies trying to break through the market.


© S&P Capital IQ 2022
All news about THERMO FISHER SCIENTIFIC
06/30Hywin Holdings, FactSet Launch Global Health Care Index
MT
06/14S&P Upgrades Thermo Fisher Scientific One Notch To 'A-' On Expected Leverage Below 3x a..
MT
06/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
06/10Illumina Shares Drop 10% After CFO Departure
DJ
06/09Illumina Says CFO Sam Samad to Depart July 8
DJ
06/09Thermo Fisher Scientific Inc Announces FDA Clears Thermo Scientific EliA RNA Pol III an..
CI
06/09Thermo Fisher Scientific Tests Get FDA Clearance
DJ
06/07Thermo Fisher Scientific Inc. Updates Applied Biosystems QuantStudio 5 Dx Real-Time PCR..
CI
06/06Thermo Fisher Scientific Inc. Showcases Solutions for Accelerating Next Generation Vacc..
CI
06/06Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine a..
BU
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 42 489 M - -
Net income 2022 6 837 M - -
Net Debt 2022 25 165 M - -
P/E ratio 2022 31,8x
Yield 2022 0,22%
Capitalization 215 B 215 B -
EV / Sales 2022 5,64x
EV / Sales 2023 5,36x
Nbr of Employees 130 000
Free-Float 88,7%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 548,27 $
Average target price 661,95 $
Spread / Average Target 20,7%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors